Table 1.
Demographic characteristics and antibody response in vaccinated group and Covid-19 cases
Vaccinated group (n=80) | Covid-19 cases (n=80) | P value | |
---|---|---|---|
Gender — no. (%) | |||
Female | 57 (71,3) | 56 (70) | 0,862 |
Male | 23 (28,8) | 24 (30) | |
Age —years | 0,081 | ||
Median (IQR) | 43,5 (33-50) | 39,5 (31,25-46) | |
Range | 21-58 | 21-64 | |
Antibody testing time | 0,806 | ||
Mean (±SD) | 44,33 (±15,929) | 44,93 (±14,930) | |
Range | 15-75 | 15-74 | |
Antibody testing time — Mean (±SD) | |||
Anti-S1 IgG seropositive | 43,91 (±15,635) | 45,55 (±14,433) | 0,502 |
Anti-S1 IgG seronegative | 55 (±23,580) | 37,17 (±20,064) | 0,358 |
Anti-S1 IgG seropositive — n (%) | 77 (96,2) | 74 (92,5) | 0,303 |
Gender in Anti-S1 IgG seropositive — n (%) | |||
Female | 55 (96,5) | 52 (92,9) | 0,516 |
Male | 22 (95,7) | 22 (91,7) | |
Titers of Anti-S1 IgG | |||
Median (IQR) | 3,169 (2,318-4,275) | 4,367 (2,552-6,407) | 0,012 |
Range | 0,482-9,145 | 0,169-10,117 | |
Anti-N total seropositive — n (%) | 41 (51,2) | 79 (98,8) | <0,0001 |
Gender in Anti-N total seropositive — n (%) | |||
Female | 32 (56,1) | 55 (98,2) | <0,0001 |
Male | 9 (39,1) | 24 (100) | |
Titers of Anti-N total | |||
Median (IQR) | 0,992 (0,369-2,895) | 34,95 (16,115-63,388) | <0,0001 |
Range | 0,08-8,85 | 0,737-149,9) |